Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Sep;69(3):351–355. doi: 10.1136/adc.69.3.351

Use of budesonide in severe asthmatics aged 1-3 years.

G J Connett 1, C Warde 1, E Wooler 1, W Lenney 1
PMCID: PMC1029518  PMID: 8215545

Abstract

The treatment of severe asthmatics aged 1-3 years with budesonide administered via Nebuhaler and Laerdal facemask was assessed in a six month, double blind, placebo controlled study. Patients were randomised to budesonide (n = 20) or placebo (n = 20) treatment. Daily symptom scores were recorded by parents and clinic visits occurred every six weeks. Cough scores improved significantly with budesonide: nocturnal and daytime cough scores (0-2) fell by a mean (SEM) of 0.4 (0.2) and 0.5 (0.2); while with placebo the nocturnal score increased by 0.1 (0.2) and daytime score was unchanged at 0.0 (0.2). All other data showed improvements for active over placebo treatment. Thirteen children in each group completed six months' treatment. Parents of 25 of these found the delivery system convenient and easy to use. While blinded to treatment it was assessed to be beneficial in nine of 13 receiving budesonide and four of 13 receiving placebo. The Nebuhaler and facemask is an acceptable delivery system for long term asthma treatment. Symptoms are significantly reduced when it is used to give 400-800 micrograms budesonide/day to children aged 1-3 years who cannot use other delivery systems.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bisgaard H., Munck S. L., Nielsen J. P., Petersen W., Ohlsson S. V. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet. 1990 Sep 15;336(8716):649–651. doi: 10.1016/0140-6736(90)92147-a. [DOI] [PubMed] [Google Scholar]
  2. Chung K. F. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax. 1986 Sep;41(9):657–662. doi: 10.1136/thx.41.9.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Everard M. L., Clark A. R., Milner A. D. Drug delivery from holding chambers with attached facemask. Arch Dis Child. 1992 May;67(5):580–585. doi: 10.1136/adc.67.5.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Geddes D. M. Inhaled corticosteroids: benefits and risks. Thorax. 1992 Jun;47(6):404–407. doi: 10.1136/thx.47.6.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Godfrey S., Avital A., Rosler A., Mandelberg A., Uwyyed K. Nebulised budesonide in severe infantile asthma. Lancet. 1987 Oct 10;2(8563):851–852. doi: 10.1016/s0140-6736(87)91033-6. [DOI] [PubMed] [Google Scholar]
  6. Hoskyns E. W., Thomson A., Decker E., Hutchins A., Simpson H. Effect of controlled release salbutamol on nocturnal cough in asthma. Arch Dis Child. 1991 Oct;66(10):1209–1212. doi: 10.1136/adc.66.10.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kamada A. K., Parks D. P., Szefler S. J. Inhaled glucocorticoid therapy in children: how much is safe? Pediatr Pulmonol. 1992 Feb;12(2):71–72. doi: 10.1002/ppul.1950120202. [DOI] [PubMed] [Google Scholar]
  8. McIntosh K., Ellis E. F., Hoffman L. S., Lybass T. G., Eller J. J., Fulginiti V. A. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr. 1973 Apr;82(4):578–590. doi: 10.1016/S0022-3476(73)80582-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mertsola J., Ziegler T., Ruuskanen O., Vanto T., Koivikko A., Halonen P. Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child. 1991 Jan;66(1):124–129. doi: 10.1136/adc.66.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Noble V., Ruggins N. R., Everard M. L., Milner A. D. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child. 1992 Mar;67(3):285–288. doi: 10.1136/adc.67.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Prahl P. Adrenocortical suppression following treatment with beclomethasone and budesonide. Clin Exp Allergy. 1991 Jan;21(1):145–146. doi: 10.1111/j.1365-2222.1991.tb00817.x. [DOI] [PubMed] [Google Scholar]
  12. Salmon B., Wilson N. M., Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child. 1990 Apr;65(4):401–403. doi: 10.1136/adc.65.4.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Soutar C. A., Carruthers M., Pickering C. A. Nocturnal asthma and urinary adrenaline and noradrenaline excretion. Thorax. 1977 Dec;32(6):677–683. doi: 10.1136/thx.32.6.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sporik R., Holgate S. T., Cogswell J. J. Natural history of asthma in childhood--a birth cohort study. Arch Dis Child. 1991 Sep;66(9):1050–1053. doi: 10.1136/adc.66.9.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Storr J., Barrell E., Barry W., Lenney W., Hatcher G. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1987 Apr 18;1(8538):879–882. doi: 10.1016/s0140-6736(87)92857-1. [DOI] [PubMed] [Google Scholar]
  16. Tal A., Levy N., Bearman J. E. Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics. 1990 Sep;86(3):350–356. [PubMed] [Google Scholar]
  17. Van Bever H. P., Schuddinck L., Wojciechowski M., Stevens W. J. Aerosolized budesonide in asthmatic infants: a double blind study. Pediatr Pulmonol. 1990;9(3):177–180. doi: 10.1002/ppul.1950090310. [DOI] [PubMed] [Google Scholar]
  18. Webb M. S., Henry R. L., Milner A. D. Oral corticosteroids for wheezing attacks under 18 months. Arch Dis Child. 1986 Jan;61(1):15–19. doi: 10.1136/adc.61.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. de Jongste J. C., Duiverman E. J. Nebulised budesonide in severe childhood asthma. Lancet. 1989 Jun 17;1(8651):1388–1388. doi: 10.1016/s0140-6736(89)92831-6. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES